GSK to Cut Jobs, Outsource U.K. Unit

GlaxoSmithKline (GSK) says that during the next two years it plans to reduce its workforce and focus production solely on final-stage pharmaceutical manufacturing at its Ulverston, U.K. site. The measures, part of a wider program to reduce costs, would lead to 330 job cuts at Ulverston, about 61% of its workforce there. GSK says it plans to outsource pharma intermediates currently manufactured at the site to contract manufacturers“at globally competitive...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers